Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06484504 · ClinicalTrials.gov registry record · NA
Effect of Kombucha Consumption on the Microbiome in Healthy Subjects
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT06484504 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 31 participants.
The verdict
NCT06484504, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
This proposed pilot study will assess the ability of consumption of two servings of kombucha daily to decrease inflammation, alter the gut microbiome composition, and improve intestinal wellbeing in a free-living population. The primary objective is to determine changes in the fecal microbiome composition. Secondary outcomes will be bacterial metabolites (fecal indole propionic acid, calprotectin), serum interleukin (IL) 6, interleukin (IL) 10, C-reactive protein (CRP), C-peptide, insulin, fasting glucose, Homeostatic Model Assessment for Insulin Resistance (HOMA), 14-day continuous glucose monitor, digestive health, dietary information, general Health \& Wellness at 4 and 8 weeks.
Interventions
- DIETARY_SUPPLEMENT Kombucha beverage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-03-03 |
| Est. Completion | 2024-04-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06484504
The ClinicalTrials.gov registry entry for NCT06484504 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Kombucha beverage is the first listed.
NCT06484504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06484504 about?
NCT06484504 is a clinical study titled "Effect of Kombucha Consumption on the Microbiome in Healthy Subjects". This proposed pilot study will assess the ability of consumption of two servings of kombucha daily to decrease inflammation, alter the gut microbiome composition, and improve intestinal wellbeing in a free-living population. The primary objective is to determine changes in the fecal microbiome compo...
What is the current status of trial NCT06484504?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2022-03-03. Estimated completion is 2024-04-25.
What interventions are being tested in trial NCT06484504?
The interventions under investigation include: Kombucha beverage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06484504?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.